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Report From the International Registry of Acute Aortic Dissection
ossella Fattori, MD,* Thomas T. Tsai, MD,† Truls Myrmel, MD, PHD,
rturo Evangelista, MD, FESC,¶ Jeanna V. Cooper, MS,† Santi Trimarchi, MD,‡
in Li, MS,† Luigi Lovato, MD,* Stephan Kische, MD,§ Kim A. Eagle, MD,†
ric M. Isselbacher, MD,# Christoph A. Nienaber, MD, FACC, FESC§
ologna and Milano, Italy; Ann Arbor, Michigan; Rostock, Germany; Tromsø, Norway;
arcelona, Spain; and Boston, Massachusetts
bjectives Impact on survival of different treatment strategies was analyzed in 571 patients with
cute type B aortic dissection enrolled from 1996 to 2005 in the International Registry of Acute
ortic Dissection.
ackground The optimal treatment for acute type B dissection is still a matter of debate.
ethods Information on 290 clinical variables were compared, including demographics; medical
istory; clinical presentation; physical ﬁndings; imaging studies; details of medical, surgical, and en-
ovascular management; in-hospital clinical events; and in-hospital mortality.
esults Of the 571 patients with acute type B aortic dissection, 390 (68.3%) were treated medically,
9 (10.3%) with standard open surgery and 66 (11.6%) with an endovascular approach. Patients who
nderwent emergency endovascular or open surgery were younger (mean age 58.8 years, p 
.001) than their counterparts treated conservatively, and had male preponderance and hyperten-
ion in 76.9%. Patients submitted to surgery presented with a wider aortic diameter than patients
reated by interventional techniques or by medical therapy (5.36  1.7 cm vs. 4.62  1.4 cm vs.
.47  1.4 cm, p  0.003). In-hospital complications occurred in 20% of patients subjected to endo-
ascular technique and in 40% of patients after open surgical repair. In-hospital mortality was signif-
cantly higher after open surgery (33.9%) than after endovascular treatment (10.6%, p  0.002).
fter propensity and multivariable adjustment, open surgical repair was associated with an in-
ependent increased risk of in-hospital mortality (odds ratio: 3.41, 95% conﬁdence interval:
.00 to 11.67, p  0.05).
onclusions In the International Registry of Acute Aortic Dissection, the less invasive nature of en-
ovascular treatment seems to provide better in-hospital survival in patients with acute type B dis-
ection; larger randomized trials or comprehensive registries are needed to access impact on
utcomes. (J Am Coll Cardiol Intv 2008;1:395–402) © 2008 by the American College of Cardiology
oundation
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396ptimal therapeutic management of patients with acute
ype B dissection is controversial. The effective use of
edical therapy and gradual improvement of surgical tech-
iques may have resulted in better prognosis in patients with
cute ascending aortic dissection, whereas for many years no
ubstantial therapeutic concept has emerged for improved
anagement of type B dissection. Because of high morbid-
ty and mortality associated with surgery of the descending
orta, medical treatment is generally advocated for uncom-
licated cases. However, about 30% of acute type B dissec-
ions at clinical presentation are complicated by peripheral
ascular ischemia or hemodynamic instability, with a sub-
equent high risk of spontaneous death (1–9).
See page 403
Recently, endovascular techniques have provided addi-
ional opportunities in the treatment of descending aortic
iseases (10–12). Initial studies demonstrated technical
easibility of endovascular approaches even to tackle the
ifficult clinical scenario of type B dissection (13–20). We
tilize the resources of the IRAD (International Registry of
cute Aortic Dissection) to analyze clinical characteristics,
imaging findings, and in-
hospital outcomes of patients
with type B dissection submitted
on an emergency basis to opera-
tive intervention, both endovas-
cular and conventional open sur-
gery.
ethods
he IRAD is a multinational registry of 20 referral centers
n 9 countries designed to provide an unbiased representa-
ive population of patients with acute aortic dissection. Full
etails of the IRAD methods and structure of IRAD have
een previously described (21–25). Data were obtained from
ospital records of 1,554 patients enrolled in IRAD with
cute aortic dissection between 1996 and 2005, 571 of
hom were classified as acute type B aortic dissection.
tudy population. We examined data on all patients with
cute type B aortic dissection enrolled in IRAD who were
reated medically or underwent emergency intervention in
he acute phase. Acute type B aortic dissection was defined
s any spontaneously occurring nontraumatic dissection
nvolving the descending aorta diagnosed within 14 days of
ymptom onset (26). Patients were identified prospectively
t the time of presentation or retrospectively from discharge
iagnosis, and from imaging and surgical databases. Diag-
osis was based upon confirmatory imaging, surgical visu-
lization, or autopsy. Surgical repair was performed by open
bbreviations
nd Acronyms
I  confidence interval
VA  cerebrovascular
ccident
R  odds ratiohoracotomy with interposition grafting or open surgical sxcision of the intimal layer while endovascular techniques
onsisted of stent-graft placement in the descending aorta
sing commercially available stent-graft or percutaneous
enestration with or without vessel stenting, according to
tandard methods.
ata collection. Data were collected on standardized forms
ith standard IRAD definitions. Information on 290 clin-
cal variables was collected including patient demographics;
edical history; clinical presentation; physical findings;
maging studies; details of medical, surgical, and endovas-
ular management; in-hospital clinical events; length of
tay; and in-hospital mortality. Data forms were reviewed
or internal consistency and validity and then scanned
lectronically into an Access database by the IRAD coor-
inating center at the University of Michigan.
tatistical analysis. Data are shown as frequencies and
ercentages, and mean  SD. Missing data were not
efaulted to negative, and denominators reflect only re-
orted cases. Associations of death among nominal variables
ere compared using the chi-square test or Fisher exact test
hen appropriate, and among continuous variables using
he Student t test.
Because surgery or endovascular treatment was not ran-
omly assigned in this population, potential confounding
nd selection biases were addressed by developing a propen-
ity score for surgical treatment. Bivariate and multivariate
nalyses of clinical variables were used to generate the
robability of receiving surgery. Multivariate logistic regres-
ion was used to determine the independent risk of surgery
or in-hospital mortality after maximal adjustment. Initial
odeling used variables marginally suggestive of an unad-
usted association to in-hospital mortality (p  0.20).
ultistage logistic regression analysis modeled the associa-
ion between in-hospital death and surgery to assess the
ncremental impact of propensity, multivariate, and both
djustment methods on the odds of death. The probability
as also used to divide the population according to quartiles
f propensity score and to compare in-hospital mortality in
his selected cohort. Odds ratios (ORs), 95% confidence
ntervals (CIs), and p values are reported. SPSS 14.0
oftware (SPSS Inc., Chicago, Illinois) and SAS Version 8.2
SAS Institute, Cary, North Carolina) were used for all
nalyses.
esults
emographics and patients’ history. Of the 1,554 patients
ith acute aortic dissection enrolled in IRAD, 571 (36.7%)
uffered an acute type B aortic dissection. Of these, 390
atients were treated medically and 125 were managed with
ither open surgery (59 patients), or an endovascular ap-
roach (66 patients). All patients were initially treated with
ggressive antihypertensive and anti-impulse therapy; the
ubset with complicated type B dissection eventually sub-
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397ected to emergency care were younger than those treated
ith medical therapy alone, with a mean age of 58.8 years
ith stent-graft treatment, and 61.9 years with open surgery
ersus 65.5 years for the remainder (p  0.001). Male
atients were preponderant among cases with complicated
issection (Table 1). No significant difference was observed
ith respect to etiology of dissection; however, even though
he small number does not allow statistical significance, in
5 patients with Marfan syndrome and type B dissection, 9
60%) were considered complicated during the acute phase
nd received endovascular or open surgical treatment.
linical presentations, signs, and diagnostic imaging results.
ain characteristics of patients submitted to emergency
reatment was described as worst ever, migrating and with
bdominal location (Table 2). Most patients were hyper-
ensive on admission, but symptoms associated with malp-
rfusion, such as limb and visceral ischemia, were more
ommon in patients treated by percutaneous fenestration (p
0.001). Initial diagnostic tools, such as chest X-ray or
lectrocardiogram, did not reveal significant difference be-
ween stable and unstable patients. In patients who under-
ent endovascular treatment, an angiographic or magnetic
esonance imaging evaluation of the thoracic aorta was used
ore often than in patients treated medically or with
onventional surgery (p 0.01 and p 0.001, respectively).
lear localization of the entry site in the descending aorta (p
0.001) and involvement of abdominal vessels (p  0.02)
ere more common in patients treated with endovascular
echniques. The widest aortic diameter (5.36 1.7 cm) was
bserved in patients subjected to open surgery, while the
Table 1. Demographics and History of Patients With Acute Type B Dissect
Variable
Medical Treatment
(n  390)
Endo
(Stent-Graft
(n
n (%) 390 (75.7) 6
Demographics
Age, mean ( SD), yrs 65.5 (13.2) 58.
Gender, male (%) 254 (65.1) 4
Etiology and patients’ history
Marfan syndrome (%) 6 (1.6)
Hypertension (%) 295 (76.6) 5
Atherosclerosis (%) 150 (39.6) 1
Bicuspid aortic valve (%) 5 (2.1)
Iatrogenic dissection (%) 16 (4.5)
Prior aortic dissection (%) 23 (6.1)
Prior aortic aneurysm (%) 69 (18.2)
Diabetes (%) 21 (5.6)
Prior cardiac surgery (%) 67 (18.4) 1
*Overall p value for the 3 groups; — numbers too small for p value.ndovascular group (4.62  1.3 cm) and the medically wreated patients (4.47 1.4 cm) had smaller aortic diameters
p  0.003).
ndications for treatment and treatment modalities (surgical
nd endovascular). The 59 open surgical procedures in-
luded interposition grafting in 56 patients and surgical
enestration in the remaining 3 by open thoracotomy.
atients submitted to open surgery were treated early
ompared with patients subjected to endovascular tech-
iques (81.6  114.9 h vs. 217.0  191.6 h, p  0.001)
Table 3). In the open surgery subset of patients, the most
ommon reason for treatment was extension of dissection
47%, p  0.003), but a significant proportion also had
ecurrent and refractory pain (22.0% and 15.3%, respec-
ively), visceral ischemia 18.6%, and limb ischemia 11.9%
Table 3). Endovascular techniques consisted of stent-graft
lacement in the descending aorta in 43 patients and
ercutaneous fenestration in 23 patients. The most frequent
easons for treatment were recurrent (46.3%) or refractory
ain (19.5%) in the stent-graft group while limb (42.9%)
nd visceral ischemia (42.9%) were the most common
ndications for patients treated with percutaneous fenestra-
ion. However, extension of dissection was seen as a
requent indicator of disease progression and instability in
he endovascular stent-graft and fenestration groups (11
26.8%] and 2 [9.5%] patients, respectively).
n-hospital complications and mortality. In-hospital compli-
ations occurred in 21% of patients subjected to an endo-
ascular technique and in 40% of patients undergoing open
nterposition grafting or fenestration (p  0.04) (Table 4).
cute renal failure and cerebrovascular accident (CVA)
reated Medically (390 Patients) and Treated in Emergency (125 Patients)
Emergency Treatment
(n  125)
p Value*
lar
estration)
Surgery
(Interposition Grafting or Fenestration)
(n  59)
) 59 (11.5)
) 61.9 (14.7) 0.001
) 46 (78.0) 0.11
6 (10.5) —
) 41 (70.7) 0.34
) 17 (30.4) 0.07
0 (0.0) —
0 (0.0) —
10 (17.9) —
) 16 (28.6) 0.07
6 (10.9) —
) 14 (25.0) 0.47ion, T
vascu
or Fen
 66)
6 (12.8
8 (11.1
7 (71.2
3 (4.6)
4 (81.8
7 (26.2
0 (0.0)
1 (1.5)
4 (6.2)
8 (12.3
4 (6.2)
1 (17.2ere frequent complications in both groups. Conversely,
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398araplegia was observed in 3 patients treated with open
urgery, and 1 patient each after stent-graft and fenestra-
Table 2. Clinical Presentations, Signs, and Diagnostic Imaging Results
Variable
Medical Treatment
(n  390)
Clinical presentations and signs
Pain severity (%)
Mild 25 (7.8)
Severe 236 (73.3)
Worst ever 61 (18.9)
Abrupt onset of pain (%) 323 (85.9)
Migrating pain (%) 64 (17.7)
Abdominal pain (%) 126 (34.2)
Leg pain (%) 27 (7.4)
Presenting hemodynamics (%)
Hypertension 269 (70.8)
Shock 12 (3.2)
Neurological signs and symptoms (%)
CVA 9 (2.3)
Coma/altered consciousness 10 (2.7)
Signs of malperfusion (%)
Ischemic spinal cord damage 8 (2.1)
Mesenteric ischemia/infarction (pre-op) 11 (3.1)
Acute renal failure (pre-op) 45 (12.6)
Limb ischemia (pre-op) 14 (3.9)
Any pulse deﬁcit 56 (16.1)
Any of the above signs of malperfusion 64 (18.4)
Diagnostic imaging results (%)
Chest X-ray
Pleural effusion 62 (17.9)
Wideness of the mediastinum 178 (49.7)
Electrocardiogram
Normal 119 (31.7)
Nonspeciﬁc ST-T changes 163 (45.8)
New Q-wave/ST-segment elevations 6 (1.7)
Low voltage 6 (1.8)
Findings on diagnostic imaging
Number of imaging studies, mean (SD) 1.94 (0.8)
TEE (%) 238 (69.2)
CT (%) 370 (94.9)
MRI (%) 92 (23.6)
AG (%) 72 (20.9)
Periaortic hematoma (%) 61 (17.1)
Site of intimal tear (%)
Arch 25 (8.4)
Descending 104 (34.8)
Multiple 8 (2.7)
Abdominal vessel involvement (%) 121 (31.1)
Widest diameter of descending aorta, mean  SD (cm) 4.47 (1.4)
AG angiography; CT computed tomography; CVA cerebrovascular accident; MRImagnetiion. Relief of visceral and limb ischemia was observed in 9 cf 18 patients subjected to percutaneous fenestration, in 16
f 17 patients after stent-graft, and in 4 of 14 patients after
Emergency Treatment
p Value
Endovascular
nt-Graft or Fenestration)
(n  66)
Surgery
(Interposition Grafting or Fenestration)
(n  59)
0 (0.0) 0 (0.0) —
31 (59.6) 34 (72.3) 0.13
21 (40.4) 13 (27.7) 0.002
56 (88.9) 49 (86.0) 0.81
25 (38.5) 7 (13.0) 0.001
35 (53.8) 22 (39.3) 0.01
12 (19.0) 6 (11.5) —
50 (76.9) 26 (46.4) 0.001
0 (0.0) 3 (5.0) —
0 (0.0) 1 (1.7) —
2 (3.1) 3 (5.3) —
0 (0.0) 4 (6.9) —
8 (12.3) 7 (13.7) —
12 (18.5) 3 (5.7) 0.11
14 (21.5) 8 (15.7) —
12 (20.3) 11 (20.0) 0.60
25 (39.1) 15 (29.4) 0.001
10 (17.2) 8 (14.8) 0.86
26 (44.8) 36 (64.3) 0.08
26 (41.9) 18 (31.0) 0.27
17 (28.3) 21 (38.2) 0.03
0 (0.0) 5 (9.3) —
0 (0.0) 1 (1.9) —
2.63 (1.0) 2.02 (0.7) 0.001
42 (65.6) 32 (65.3) 0.75
60 (90.9) 55 (93.2) —
25 (37.9) 9 (15.3) 0.01
43 (66.2) 21 (38.9) 0.001
10 (16.9) 14 (25.0) 0.35
5 (8.3) 4 (8.0) —
40 (66.7) 12 (24.0) 0.001
6 (10.0) 2 (4.0) —
32 (48.5) 18 (30.5) 0.02
4.62 (1.3) 5.36 (1.7) 0.003
ance imaging; TEE transesophageal echocardiography.(Steonventional open surgery (Tables 3 and 4). In-hospital
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399ortality was significantly higher after open surgery (inter-
osition grafting and open fenestration, 20 of 59 patients,
3.9%) than after endovascular treatment (stent-graft place-
ent and percutaneous fenestration, 7 of 66 patients,
0.6%, p  0.002).
After multivariate adjustment, surgery versus endovascu-
ar treatment in patients with complicated acute type B
ortic dissection was independently associated with in-
ospital mortality (OR: 3.89; 95% CI: 1.27 to 11.91; p 
.02) (Table 5). In multistage logistic regression, the asso-
iation between surgery and in-hospital mortality remained
ignificant with propensity adjustment alone and multivar-
ate adjustment including propensity score. Furthermore,
uartiles 2 and 3 (Fig. 1) of propensity matched quartiles
ere used for further analysis because of the balance of
urgical and endovascular patients in this group. Mortality
as significantly higher in patients treated with surgery
ersus patients treated with endovascular therapy (43.8% vs.
.9%, p  0.006). Patients treated with stent-graft place-
ent in the descending aorta showed the lowest mortality (4
f 43 patients, 9.3%), which is similar to the mortality of
Table 3. Treatment: Timing and Indications
Variable
End
With Fenestration Only
 Bare Stent
(n  23)
Hours from diagnosis to treatment, mean (SD) 36.9 (38.6)
Hours from treatment to discharge, mean (SD) 955.1 (2,307.9)
Reason for treatment (%)
Recurrent pain 3 (14.3)
Refractory pain 3 (14.3)
Limb ischemia 9 (42.9)
Visceral ischemia 9 (42.9)
Extension of dissection 2 (9.5)
Refractory hypertension 4 (19.0)
Table 4. In-Hospital Complications and Mortality of Repair of the Descendi
66 Patients), and Open Surgical Techniques (Surgical Interposition Graftin
Variable
Endovascular (6
With Stent-Graft P
Aorta or Fene
In-hospital complications (post-treatment) (%)
CVA 2 (3.4
Coma 1 (1.7
Spinal cord ischemia 2 (3.4
Myocardial infarction 1 (1.8
Mesenteric ischemia/infarction 4 (7.4
Acute renal failure 4 (7.4
Limb ischemia 2 (3.6
Any of the above complications 11 (20.
Mortality (%) 7 (10.CVA cerebrovascular accident.atients treated medically (34 of 390 patients, 8.7%). CVA
nd persistent visceral ischemia were the main causes of
eath after stent-graft placement and fenestration, while
ortic rupture was the most frequent cause of death in
atients submitted to open surgery, reported in 13 of 19
atients (Fig. 2). Kaplan-Meier overall in-hospital survival
stimates were significantly better for medical and endovas-
ular patients with respect to patients submitted to open
urgery (Fig. 3) (medical vs. surgical p  0.001, endovas-
ular vs. surgical p  0.001).
iscussion
he appropriate treatment strategy for descending aortic
issection has long been a matter of debate and continues to
e a challenge. There is a general agreement that patients
ith an initially uncomplicated type B aortic dissection
hould not receive open surgery but rather medical therapy
ocusing on beta-blockers to decrease the force of cardiac
ontraction on the aortic wall and reducing blood pressure
n patients with aortic medial disease (27,28). Meanwhile,
ular
Surgical With Interposition
Grafting or Fenestration
(n  59) p Value
ith Stent-Graft Placement
in Aorta
(n  43)
217.0 (191.6) 81.6 (114.9) 0.001
342.9 (213.4) 661.0 (744.8) 0.15
19 (46.3) 13 (22.0) 0.008
8 (19.5) 9 (15.3) —
8 (19.5) 7 (11.9) —
9 (22.0) 11 (18.6) 0.08
11 (26.8) 28 (47.5) 0.003
8 (19.5) 8 (13.6) —
rta by Percutaneous Techniques (Stent-Graft or Fenestration,
enestration, 59 Patients)
ents)
ent in
on
Surgical (59 Patients)
With Interposition Grafting
or Fenestration p Value
4 (9.1) 0.40
2 (4.5) 0.58
3 (6.8) 0.65
1 (2.6) 0.99
2 (4.9) 0.70
8 (19.0) 0.09
2 (5.0) 0.99
16 (40.0) 0.04
20 (33.9) 0.002ovasc
Wng Ao
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400apid diagnosis, intensive monitoring, and aggressive blood
ressure management are factors likely to improve outcome.
owever, in about one-third of patients, specific initial
ndings such as refractory hypertension, recurrent pain, or
alperfusion indicate instability, which may require a more
ggressive approach (4). Unfortunately, despite significant
mprovement in anesthesia, surgical techniques, and post-
perative care, mortality of emergent open surgical repair of
cute type B dissection remains high (25% to 50%) in many
eports, and only a few single-center series have reported
ore favorable results (8,9).
Recently, the advent of endovascular techniques has
rovided new therapeutic options to the treatment of
horacic aortic diseases (13,14). Initial series and subsequent
ulticenter trials demonstrated technical feasibility and a
ow rate of complications even in high-risk patients with
ype B dissection unfit for open surgery (11,12). First
pplied in the treatment of abdominal and thoracic aneu-
ysm, results of stent-graft treatment on thoracic aortic
issection showed the potential for improved survival with
espect to open surgery, especially in unstable patients with
Figure 1. Propensity-Matched Quartiles
In quartiles 1 and 4, the patients are less well matched and are treated
predominantly with endovascular therapy in quartile 1 and surgery in quar-
tile 2. Quartiles 2 and 3 are well matched and balanced with regard to
Table 5. Association Between Surgery and In-Hospital Mortality in Patients
With Acute Complicated Type B Aortic Dissection: Effect of Multivariate
Adjustment (Endovascular Treatment in the Reference Group)
Model Odds Ratio 95% CI p Value
Unadjusted 4.25 1.64–11.00 0.003
Multivariate adjustment* 3.89 1.27–11.91 0.02
Propensity† 3.46 1.25–9.62 0.02
Propensity and multivariate adjustment 3.41 1.00–11.67 0.05
*Surgery/endovascular, female gender, age65 years, chest/back pain, abnormal aortic contour,
periaortic hematoma,malperfusion;†age65 years, female gender, site of intimal tear (descend-
ing), migrating pain, abnormal aortic contour, treatmentwith beta-blockers or vasodilators.
CI confidence interval.therapy (16 surgery and 29 endovascular therapy).mpending rupture. However, a direct comparison between
tent-graft and conventional open surgery is scarce. The
RAD database offers a unique opportunity to analyze
utcomes in large numbers of consecutive patients treated
or aortic dissection in 20 referral centers around the world.
he IRAD analysis, which reflects the “real-word” scenario,
upports the premise of potential advantages in survival of
ndovascular compared with open surgical strategies. While
ndovascular reconstruction of complicated type B dissec-
ion lowered short-term mortality to the level of uncompli-
ated type B dissection with medical treatment, conven-
ional surgery confirmed the high mortality associated with
he open approach. Of course, since our study is not
andomized, part of this association may be related to
election bias in treatment modality and may reflect differ-
nt treatment strategy in different institutions. It is impor-
rupturevisceral ischemianeurologic
Cause of death
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401ant to note that in the first years of IRAD enrollment (1996
o 2000), stent-graft treatment was possible only in few
eferral centers; therefore, it was not reflecting of common
ractice at community hospitals. Nowadays technical evo-
ution and wider diffusion of aortic stent-graft allow imme-
iate emergency treatment of complicated type B dissection
n many centers. On the contrary, in the first years of IRAD,
he extended period (from 4 to 7 days) necessary for
roviding a custom-made stent-graft may have contributed
o clinical selection bias. Patients treated with conventional
urgical approach had a widest aortic diameter and periaor-
ic hematoma and were treated earlier than patients submit-
ed to endovascular repair, suggesting a subset of patients at
greatest risk. However, potential confounding and selec-
ion biases were minimized by developing a propensity score
or surgical treatment to balance the covariates in the
urgical and endovascular groups. After propensity adjust-
ent alone and propensity with regression adjustment, the
oint estimate remained significant for an increased mor-
ality with open surgery versus endovascular treatment.
urthermore, when evaluating mortality in quartiles 2 and
, which represents a balanced treatment and covariate mix,
ortality is highest in the surgically treated cohort (Table
). There remain methodological concerns when using
ropensity and regression adjustments, which are only as
good” as the measured covariates and the decision to
erform urgent open surgery versus endovascular therapy
ay not be easily captured. The evolution of stent-grafts to
over the primary tear and expanded indications for surgery
rom centers around the world make heterogeneity between
urgical versus endovascular indications a significant issue.
onetheless, propensity with covariate adjustment attempts
o minimize this selection bias.
Imaging modalities have evolved in recent years to allow
ore rapid, detailed, and noninvasive diagnosis in aortic
issection; nevertheless, from 390 patients deemed stable
nd treated medically, 34 died during in-hospital course,
mphasizing how recognition of an unstable condition
emains a challenge. Malperfusion from aortic branch-vessel
bstruction is one of the most important causes of morbidity
nd mortality in type B dissection, with mortality rate for
atients with compromised visceral perfusion ranging from
3% to 50% (29). The mechanisms may involve a static
arrowing of the vessel lumen by means of aortic wall
ematoma or dynamic obstruction by means of the dissec-
ion flap prolapsing into the side branch orifice. Surgical
Table 6. Mortality for Combined Quartile 2 and Quartile 3
Models
Surgery 16
(35.6%)
Endovascular 29
(64.4%) p Value
Mortality 7 2 0.006
43.8% 6.9%enestration, despite a wide array of open surgical strategies, thowed a high mortality even in recent series (29–32).
ecause of more rapid access and limited blood loss,
ercutaneous techniques provided better results, with overall
echnical success exceeding 90%, and 30-day mortality of
5% (33–35). In the series reported from IRAD, mortality
f patients submitted to endovascular fenestration was very
ow (3 of 23 patients, 13%), and in all cases the cause of
eath was determined by persistent visceral ischemia despite
he technical success of fenestration. The purpose of both
urgical and percutaneous fenestration techniques is to
reate a communication between the 2 aortic lumens in
rder to equalize pressure and flow in both of the lumens
nd in their branch vessels. However, both intimal flap
xcision and enlargement of re-entry site by balloon infla-
ion may fail to stabilize for aortic rupture or late lumen
ilation (36). Conversely, by the physiologic effect of stent-
raft closure of the entry site, flow is directed exclusively
oward the true lumen improving branch vessel perfusion
ith a less traumatic approach. In the present series, a relief
f visceral ischemia was observed in 16 of 17 patients with
alperfusion syndrome submitted to stent-graft placement,
n 9 of 18 treated with percutaneous fenestration, and in just
of 14 patients treated with open surgery.
tudy limitations. Some considerations are important in
nterpreting the results of this study. First, the IRAD cohort
s referred to patients treated at centers specialized in aortic
isease, and therefore may not reflect management of
atients treated at community hospitals. Second, in IRAD,
atient entries were not randomized to a pre-determined
reatment strategy and rather reflect a retrospective obser-
ation, and results may partially be related to selection bias.
urthermore, even after maximal adjustment with the aid of
ropensity and multivariate models, the full clinical picture
hat determines the decision for surgery versus endovascular
herapy may not be fully adjusted for. Third, as all retro-
pective observational studies, the database is subject to
eferral and ascertainment bias and information on compli-
ations and cause of death may reflect different data
nterpretation.
onclusions
omplicated acute and subacute type B dissection remains
clinical challenge. Patients with complicated type B
issection and signs of clinical instability at presentation
ave a high risk of in-hospital mortality. With recognition
f clinical and imaging findings of instability, the choice of
ndovascular stent-graft placement may offer a strategy to
ptimize management and improve in-hospital prognosis.
n IRAD, endovascular treatment seems to offer better
hort-term outcome in terms of mortality and associated
omplications than open surgical repair. Long-term
ollow-up is necessary to assess late outcomes and establish
he ultimate treatment strategy.
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